BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18653640)

  • 1. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.
    Martins CL; Garly ML; Balé C; Rodrigues A; Ravn H; Whittle HC; Lisse IM; Aaby P
    BMJ; 2008 Jul; 337():a661. PubMed ID: 18653640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.
    Aaby P; Martins CL; Garly ML; Balé C; Andersen A; Rodrigues A; Ravn H; Lisse IM; Benn CS; Whittle HC
    BMJ; 2010 Nov; 341():c6495. PubMed ID: 21118875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.
    Martins CL; Benn CS; Andersen A; Balé C; Schaltz-Buchholzer F; Do VA; Rodrigues A; Aaby P; Ravn H; Whittle H; Garly ML
    J Infect Dis; 2014 Jun; 209(11):1731-8. PubMed ID: 24436454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
    Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
    Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.
    Rasmussen SM; Biering-Sørensen S; Byberg S; Andersen A; Bjerregaard-Andersen M; Rodrigues A; Benn CS; Martins CL; Aaby P
    BMC Pediatr; 2016 Dec; 16(1):199. PubMed ID: 27912735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.
    Fisker AB; Nebie E; Schoeps A; Martins C; Rodrigues A; Zakane A; Kagone M; Byberg S; Thysen SM; Tiendrebeogo J; Coulibaly B; Sankoh O; Becher H; Whittle HC; van der Klis FRM; Benn CS; Sie A; Müller O; Aaby P
    Clin Infect Dis; 2018 May; 66(10):1573-1580. PubMed ID: 29177407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
    Martins C; Garly ML; Bale C; Rodrigues A; Njie-Jobe J; Benn CS; Whittle H; Aaby P
    J Infect Dis; 2014 Sep; 210(5):693-700. PubMed ID: 24688075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
    Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
    Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.